Kangwen Lin

Title: Kangwen Lin: Innovator in Pharmaceutical Formulations

Introduction

Kangwen Lin is a notable inventor based in Sharon, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance drug delivery and efficacy. His work is characterized by a focus on creating stable and effective pharmaceutical compositions.

Latest Patents

Kangwen Lin holds a patent for a "Stabilized, acid-free formulation for sustained release of bupropion hydrochloride." This innovative formulation is free of acid additives and allows for a sustained release of bupropion hydrochloride. The patent details that the particulate bupropion hydrochloride may be coated with a membrane coating, and large-size particles can also be utilized. Additionally, methods for treating individuals using these stabilized pharmaceutical compositions are provided.

Career Highlights

Kangwen Lin is currently associated with Teva Pharmaceuticals USA, Inc., where he continues to advance his research and development efforts. His work at Teva has positioned him as a key player in the pharmaceutical industry, contributing to the development of effective treatments for various conditions.

Collaborations

Kangwen Lin collaborates with Shubha Chungi, a fellow professional in the field. Their partnership exemplifies the collaborative spirit that drives innovation in pharmaceutical research.

Conclusion

Kangwen Lin's contributions to pharmaceutical formulations, particularly his patented work on bupropion hydrochloride, highlight his role as an innovator in the industry. His ongoing efforts at Teva Pharmaceuticals USA, Inc. continue to impact the field positively.